Despite the continuous improvement in the efficacy of allogeneic hematopoietic stem cell transplantation(allo-HSCT),acute graft-versus-host disease(GVHD)remains a major complication and cause of death.In recent years,with the emergence of new drugs for the prevention and treatment of acute GVHD and the update of a series of clinical studies,there have been varying degrees of changes in the routine prevention and treatment regimens for acute GVHD.Based on the main research achievements and the accumulation of clinical experience in this field in recent years,this consensus further updates the"The Consensus on Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Diseases in China-Acute Graft-Versus-Host Disease(2020).
NETL
NSTL
万方数据
